Muscle & Performance Research Peptides South Africa

Tesamorelin Research: What the Studies Show

Tesamorelin has something almost no other research peptide has: multiple large, placebo-controlled human phase III trials and a regulatory approval behind it. Here is what each landmark trial actually measured, in plain English.

CJC-1295 Research: GH and IGF-1 Data from the Human Dose-Escalation Trials

A study-by-study look at CJC-1295 — the drug-affinity-complex technology behind its long half-life, and the human trials that measured its effect on GH pulsatility and IGF-1.

Ipamorelin Research: Selectivity Data, Bone Studies & the Phase 3 Ileus Trials

A study-by-study look at Ipamorelin — the selectivity data that made it notable, the bone and body-composition models, and the phase 3 trials that did not meet their primary endpoint.

Sermorelin Research: What the Studies Show

Sermorelin is a 29-amino-acid GHRH analog with an unusually long human record — it held FDA approval as Geref before being withdrawn in 2008 for commercial and manufacturing reasons, not safety. Here is what the published work actually measured.

Hexarelin Research: Trials, Data & What the Studies Show

Hexarelin produces the strongest acute growth hormone pulse of the GHRP class — and has a separate, GH-independent cardiac literature. The human endocrine data also documents desensitisation and off-target hormone release that shape how the compound is studied.